Allogeneic stem cell transplantation recipients requiring intensive care: time is of the essence

Ann Hematol. 2018 Sep;97(9):1601-1609. doi: 10.1007/s00277-018-3320-y. Epub 2018 May 2.

Abstract

The benefit of early admission of allogeneic stem cell transplantation (SCT) recipients to the intensive care unit (ICU) as soon as they develop organ injury is unknown. We performed a retrospective study on 92 patients admitted to the ICU to determine the impact of time from organ injury to ICU admission on outcome. The number of organ injuries prior to ICU admission was associated with an increased in-hospital mortality (OR 1.7, 95% CI 1-2.7, p = 0.04). Time between first organ injury and ICU admission was also associated with an increased in-hospital survival (OR 1.4, 95% CI 1.1-1.8, p = 0.02). A score combining these two covariates-the number of organ injuries/day (sum of days spent with each individual organ injury)-further improved the prediction of hospital survival. Patients with more organ injuries/day had significantly higher in-hospital mortality rate even after adjustment for refractory acute GVHD and the SOFA (OR 1.3, 95% CI 1-1.7, p = 0.02). Early ICU admission of allogeneic SCT recipients to the ICU as soon as they develop organ injury is associated with decreased in-hospital mortality.

Keywords: Allogeneic stem cell transplantation (SCT); Early admission; Intensive care unit (ICU).

MeSH terms

  • Adult
  • Critical Care / statistics & numerical data*
  • Female
  • Graft vs Host Disease / diagnosis
  • Graft vs Host Disease / mortality*
  • Graft vs Host Disease / therapy*
  • Hematologic Neoplasms / mortality
  • Hematologic Neoplasms / therapy
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Hematopoietic Stem Cell Transplantation / mortality
  • Hospital Mortality
  • Hospitalization / statistics & numerical data*
  • Humans
  • Intensive Care Units / statistics & numerical data
  • Lymphoproliferative Disorders / mortality
  • Lymphoproliferative Disorders / therapy
  • Male
  • Middle Aged
  • Retrospective Studies
  • Risk Factors
  • Time Factors
  • Time-to-Treatment* / statistics & numerical data
  • Transplantation, Homologous / adverse effects
  • Transplantation, Homologous / mortality